Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor

Nature
W E Van NostrandD D Cunningham

Abstract

Protease nexin-II (PN-II) is a protease inhibitor that forms SDS-resistant inhibitory complexes with the epidermal growth factor (EGF)-binding protein, the gamma-subunit of nerve growth factor, and trypsin. The properties of PN-II indicate that it has a role in the regulation of certain proteases in the extracellular environment. Here we describe more of the amino-acid sequence of PN-II and its identity to the deduced sequence of the amyloid beta-protein precursor (APP). Amyloid beta-protein is present in neuritic plaques and cerebrovascular deposits in individuals with Alzheimer's disease and Down's syndrome. A monoclonal antibody against PN-II (designated mAbP2-1) recognized PN-II in immunoblots of serum-free culture medium from human glioblastoma cells and neuroblastoma cells, as well as in homogenates of normal and Alzheimer's disease brains. In addition, mAbP2-1 stained neuritic plaques in Alzheimer's disease brain. PN-II was a potent inhibitor of chymotrypsin with an inhibition constant Ki of 6 x 10(-10)M. Together, these data demonstrate that PN-II and APP are probably the same protein. The regulation of extracellular proteolysis by PN-II and the deposition of at least parts of the molecule in senile plaques is consisten...Continue Reading

References

May 19, 1987·Biochemistry·C W Pratt, S V Pizzo
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D Gurwitz, D D Cunningham
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Jan 1, 1988·Developmental Neuroscience·A D ZurnD Monard
Aug 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Jan 11, 1984·Nucleic Acids Research·J DevereuxO Smithies
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D J Knauer, D D Cunningham
Jan 1, 1980·Annual Review of Biochemistry·M Laskowski, I Kato
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·D A LowD D Cunningham

❮ Previous
Next ❯

Citations

Mar 1, 1997·Medicinal Research Reviews·J Pallarés-TrujilloJ M Argilés
Nov 1, 1992·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·F Crawford, A Goate
Jan 1, 1991·Journal of Neuroscience Research·K C BreenB H Anderton
Apr 1, 1991·Journal of Neuroscience Research·P E FraserD A Kirschner
Oct 1, 1992·Journal of Neuroscience Research·K SambamurtiN K Robakis
Apr 15, 1994·Journal of Neuroscience Research·D K LahiriM R Farlow
Jan 1, 1995·Acta Neuropathologica·K JendroskaS J DeArmond
Oct 1, 1996·Journal of Molecular Neuroscience : MN·B A CitronB W Festoff
Jan 1, 1992·Journal of Molecular Neuroscience : MN·C A MarottaB Tate
Oct 1, 1993·Clinical Biochemistry·P E FraserD R McLachlan
Jan 1, 1992·Pharmacology & Therapeutics·A I BushC L Masters
Jan 11, 1991·Brain Research. Brain Research Reviews·D C GajdusekK K Hsiao
Mar 20, 1992·Brain Research. Developmental Brain Research·C A Sherman, G A Higgins
Oct 15, 1993·Brain Research. Developmental Brain Research·M OhtaJ Tateishi
Oct 1, 1991·Trends in Pharmacological Sciences·J Hardy, D Allsop
Mar 1, 1992·Trends in Pharmacological Sciences·S Gandy, P Greengard
Aug 1, 1994·Trends in Neurosciences·T B Shea
Mar 1, 1991·Neurobiology of Aging·G M ColeT Saitoh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.